(S)-Rasagiline-13C3 Mesylate

• CAT Number: R054706
• CAS Number: 1391068-00-0
• Molecular Formula: C13H17NO3S
• Molecular Weight: 270.32
• Purity: ≥95%
• Synonyms: (1S)-2,3-Dihydro-N-2-propyn-1-yl-1H-inden-1-amine-13C3 Mesylate; (S)-2,3-Dihydro-N-2-propynyl-1H-inden-1-amine-13C3 Mesylate; TVP 1022 Mesylate-13C3
• Storage: -20°C
• IUPAC Name: methanesulfonic acid;(1S)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine
• InChI: InChI=1S/C12H13N.CH4O3S/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12;1-5(2,3)4/h1,3-6,12-13H,7-9H2;1H3,(H,2,3,4)/t12-;/m0./s1/i1+1,2+1,9+1
• InChIKey: JDBJJCWRXSVHOQ-AJPOOADWSA-N
• SMILES: CS(=O)(=O)O.[13CH]#[13C][13CH2]N[C@H]1CCC2=CC=CC=C12

(S)-Rasagiline-13C3 Mesylate is a deuterated form of Rasagiline, a selective monoamine oxidase-B (MAO-B) inhibitor used in the treatment of Parkinson’s disease. The incorporation of three 13C isotopes into the Rasagiline molecule enhances its utility in metabolic studies and pharmacokinetic profiling. By providing detailed insights into the drug’s metabolic pathways and behavior in the body, (S)-Rasagiline-13C3 Mesylate helps researchers understand how the drug is processed and how it affects MAO-B activity. This information is crucial for optimizing dosing regimens and improving therapeutic outcomes.